FIELD: medicine; surgery.
SUBSTANCE: disclosed is a kit for haemostasis comprising a matrix which is a cross-linked hyaluronic acid derivative obtained by cross-linking hyaluronic acid or a salt thereof, and a diluent containing a coagulation inducing agent. Also disclosed is a method of producing said matrix, which is part of the kit, and a method of producing a haemostatic composition using said kit.
EFFECT: group of inventions provides high viscosity, degree of swelling, absorbing capacity, uniformity of particle size of composition and adhesive force.
11 cl, 16 dwg, 1 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR INJECTIONS OF HYALURONIC ACID CONTAINING HYALURONIC ACID DERIVATIVE AND DNA FRACTION, AND USE THEREOF | 2016 |
|
RU2697671C1 |
HEMOSTATIC AGENT | 2019 |
|
RU2709816C1 |
HEMOSTATIC COMPOSITIONS | 2016 |
|
RU2744694C2 |
HEMOSTATIC COMPOSITION COMPRISING HYALURONIC ACID | 2005 |
|
RU2369408C2 |
HAEMOSTATIC PREPARATION CONTAINING EXTRACT OF GOLDEN MOSS | 2011 |
|
RU2581918C2 |
FILLER WITH HYALURONIC ACID, EXHIBITING HIGH LIFTING ABILITY AND LOW INJECTION FORCE | 2019 |
|
RU2770541C1 |
HAEMOSTATIC COMPOSITION CONTAINING HYALURONIC ACID | 2009 |
|
RU2486921C2 |
FILLER WITH HYALURONIC ACID, EXHIBITING HIGH VISCOELASTICITY AND HIGH COHESION | 2019 |
|
RU2769398C1 |
FILLER EXHIBITING EXCELLENT FILLER PROPERTIES, CONTAINING A HYALURONIC ACID HYDROGEL | 2019 |
|
RU2779473C1 |
PROCOAGULANT PEPTIDES, THEIR DERIVATIVES AND THEIR APPLICATION | 2012 |
|
RU2635510C2 |
Authors
Dates
2021-01-12—Published
2017-09-06—Filed